FTC GLBA Safeguards Rule (16 CFR Part 314)vsPIC/S Guide to Good Manufacturing Practice for Medicinal Products
See exactly how FTC GLBA Safeguards Rule (16 CFR Part 314) controls map to PIC/S Guide to Good Manufacturing Practice for Medicinal Products. Pre-computed mappings, identified gaps, and coverage analysis.
According to the TheArtOfService Compliance Knowledge Graph:
FTC GLBA Safeguards Rule (16 CFR Part 314) maps to PIC/S Guide to Good Manufacturing Practice for Medicinal Products with 18% coverage across 2 directly mapped controls. Analysis of 11 FTC GLBA Safeguards Rule (16 CFR Part 314) controls identifies 9 compliance gaps — primarily concentrated in FTC Safeguards Rule: Effective Date, Small Institution Exemption and 2024-2025 Pipeline (314.5, 314.6, Coordination).
Source: TheArtOfService Knowledge Graph | 11 controls analysed | 718 frameworks | 332K+ cross-framework mappings
Control Mappings
Showing 4 of 4 mapped controls across 2 domains. Sign up to explore all 332K+ mappings across 718 frameworks.
FTC Safeguards Rule: 9 Safeguard Elements - Access, Encryption, MFA, Disposal, Change, Monitoring, Pen Test (314.4(c))(1 mappings)
FTC Safeguards Rule: Scope, Definitions and Financial Institution Applicability (16 CFR 314.1, 314.2)(3 mappings)
Related Comparisons
Other FTC GLBA Safeguards Rule (16 CFR Part 314) comparisons
Other PIC/S Guide to Good Manufacturing Practice for Medicinal Products comparisons
Stop Paying Consultants to Read Spreadsheets
AI-powered compliance intelligence across 718 frameworks — at a fraction of consulting costs.
Free
- ✓ 718 framework browser
- ✓ Cross-framework mappings (332K+)
- ✓ 824 compliance assessments
- ✓ 3 AI queries & searches per day
Professional
- ✓ Unlimited AI Compliance Advisory
- ✓ Unlimited full-text search
- ✓ Framework self-assessment
- ✓ PDF, Excel & CSV exports
What are the key differences between FTC GLBA Safeguards Rule (16 CFR Part 314) and PIC/S Guide to Good Manufacturing Practice for Medicinal Products?
FTC GLBA Safeguards Rule (16 CFR Part 314) has 11 controls across its framework, while PIC/S Guide to Good Manufacturing Practice for Medicinal Products covers 9 controls. Direct mapping analysis identifies 2 overlapping controls (18% coverage). The frameworks diverge most significantly in FTC Safeguards Rule: Effective Date, Small Institution Exemption and 2024-2025 Pipeline (314.5, 314.6, Coordination), where 5 FTC GLBA Safeguards Rule (16 CFR Part 314) controls have no direct PIC/S Guide to Good Manufacturing Practice for Medicinal Products equivalent.
How many controls map between FTC GLBA Safeguards Rule (16 CFR Part 314) and PIC/S Guide to Good Manufacturing Practice for Medicinal Products?
Of 11 total FTC GLBA Safeguards Rule (16 CFR Part 314) controls, 2 map directly to PIC/S Guide to Good Manufacturing Practice for Medicinal Products controls — representing 18% coverage. The remaining 9 controls represent compliance gaps requiring additional documentation or compensating controls to satisfy both frameworks simultaneously.
What are the compliance gaps when mapping FTC GLBA Safeguards Rule (16 CFR Part 314) to PIC/S Guide to Good Manufacturing Practice for Medicinal Products?
9 FTC GLBA Safeguards Rule (16 CFR Part 314) controls have no direct equivalent in PIC/S Guide to Good Manufacturing Practice for Medicinal Products. The highest concentration of gaps is in FTC Safeguards Rule: Effective Date, Small Institution Exemption and 2024-2025 Pipeline (314.5, 314.6, Coordination) with 5 unmapped controls. These gaps represent areas where additional controls, policies, or documentation must be created to achieve compliance with both frameworks.
Which control domains have the most gaps between FTC GLBA Safeguards Rule (16 CFR Part 314) and PIC/S Guide to Good Manufacturing Practice for Medicinal Products?
The domain with the highest gap count is FTC Safeguards Rule: Effective Date, Small Institution Exemption and 2024-2025 Pipeline (314.5, 314.6, Coordination) (5 gaps). Export the full domain-by-domain gap breakdown via the Professional tier to generate a prioritised remediation roadmap.
Related Resources
This platform provides educational compliance tools, not legal, regulatory, or professional compliance advice. Cross-framework mappings are AI-assisted interpretations and do not reproduce or replace official standards. Framework names and trademarks belong to their respective owners. Consult qualified professionals for your specific compliance requirements. See our Terms of Service.